{"filing":{"accession_number":"0001477932-26-004337","cik":"0001921865","ticker":"ASPI","company_name":"ASP Isotopes Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"aspi_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1921865/000147793226004337/aspi_8k.htm"},"events":[{"id":18247,"run_id":16397,"accession_number":"0001477932-26-004337","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"ASP Isotopes entered into exchange agreements whereby holders of approximately $109.2 million in QLE convertible notes will exchange their debt for approximately 23.2 million shares of ASPI common stock, representing approximately 17.8% of outstanding shares. This material unregistered equity issuance, conducted under Section 4(a)(2) and Regulation D exemptions, significantly dilutes existing shareholders and restructures the company's capital.","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":17000,"accession_number":"0001477932-26-004337","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"ASP Isotopes entered into exchange agreements to issue approximately 23.2 million shares of common stock (representing ~17.8% of outstanding shares) in exchange for $109.2 million in convertible notes held by QLE noteholders. While structured as a debt-for-equity exchange rather than a cash raise, this constitutes a dilutive issuance of unregistered equity securities conducted under Section 4(a)(2) and Regulation D exemptions. The transaction materially increases share count and dilutes existing shareholders, making it a significant capital event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17001,"accession_number":"0001477932-26-004337","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"ASP Isotopes announced exchange agreements whereby holders of QLE convertible notes will exchange approximately $109.2 million in principal for approximately 23.2 million shares of ASPI common stock, representing approximately 17.8% of ASPI's outstanding common stock. This is a material unregistered equity issuance that dilutes existing shareholders, fitting the definition of dilutive_issuance under Item 3.02. The transaction is expected to close on July 16, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17002,"accession_number":"0001477932-26-004337","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"ASPI announced entry into Exchange Agreements whereby holders of QLE convertible notes will exchange approximately $109.2 million in principal amount for approximately 23.2 million shares of ASPI common stock (17.8% of outstanding shares). This transaction materially restructures QLE's capital structure, reduces its debt by ~50%, and is expected to facilitate a future spin-off of QLE as a separate public company. While structured as a debt-for-equity exchange rather than a traditional M\u0026A transaction, the magnitude (17.8% dilution), strategic purpose (capital structure simplification and spin-off preparation), and expected closing date (July 16, 2026) align with material corporate restructuring activity reportable under Item 1.01 or 2.01 frameworks.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17000,"accession_number":"0001477932-26-004337","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"ASP Isotopes entered into exchange agreements to issue approximately 23.2 million shares of common stock (representing ~17.8% of outstanding shares) in exchange for $109.2 million in convertible notes held by QLE noteholders. While structured as a debt-for-equity exchange rather than a cash raise, this constitutes a dilutive issuance of unregistered equity securities conducted under Section 4(a)(2) and Regulation D exemptions. The transaction materially increases share count and dilutes existing shareholders, making it a significant capital event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-07-15"},{"id":17001,"accession_number":"0001477932-26-004337","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"ASP Isotopes announced exchange agreements whereby holders of QLE convertible notes will exchange approximately $109.2 million in principal for approximately 23.2 million shares of ASPI common stock, representing approximately 17.8% of ASPI's outstanding common stock. This is a material unregistered equity issuance that dilutes existing shareholders, fitting the definition of dilutive_issuance under Item 3.02. The transaction is expected to close on July 16, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-07-15"},{"id":17002,"accession_number":"0001477932-26-004337","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"ASPI announced entry into Exchange Agreements whereby holders of QLE convertible notes will exchange approximately $109.2 million in principal amount for approximately 23.2 million shares of ASPI common stock (17.8% of outstanding shares). This transaction materially restructures QLE's capital structure, reduces its debt by ~50%, and is expected to facilitate a future spin-off of QLE as a separate public company. While structured as a debt-for-equity exchange rather than a traditional M\u0026A transaction, the magnitude (17.8% dilution), strategic purpose (capital structure simplification and spin-off preparation), and expected closing date (July 16, 2026) align with material corporate restructuring activity reportable under Item 1.01 or 2.01 frameworks.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:06:08.674421+00:00","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-07-15"}]}